I. Rivière

Oncology · 2002–2018

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

Whom I. Rivière trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Brentjens

Who trusts I. Rivière overall

  1. Jennifer N. Brudno
  2. Jang-Hwan Cho
  3. C. Dunbar
  4. J. Kochenderfer
  5. S. Maude
  6. James J. Collins
  7. Michel Sadelain
  8. K. High
  9. S. Rafiq

Papers from I. Rivière's perspective

Ordered by how strongly the researchers I. Rivière trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  2. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
  3. The basic principles of chimeric antigen receptor (CAR) design (Cancer Discovery)
  4. Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells (Cancer Discovery)
  5. C-reactive protein: a critical update. (Journal of Clinical Investigation)
  6. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities (Nature Reviews Clinical Oncology)
  7. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with… (Blood)
  8. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. (Advances in Immunology)
  9. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (New England Journal of Medicine)
  10. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. (Blood)

Their papers